Utility of Readily Available Sugammadex for Emergent Neuromuscular Blockade Reversal
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Creating an emergent reversal kit significantly reduced the time for anesthesia providers to administer sugammadex during simulated can't intubate, can't ventilate (CICV) events. This improves emergency preparedness by ensuring faster access to critical medications.
Area Of Science
- Anesthesiology
- Emergency Medicine
- Quality Improvement
Background
- Anesthesia providers face challenges obtaining sufficient sugammadex for emergent reversal in can't intubate, can't ventilate (CICV) scenarios.
- Current operating room stocking of sugammadex is often insufficient for immediate, high-dose reversal needs.
- A need exists to improve the accessibility of sugammadex for critical airway events.
Purpose Of The Study
- To evaluate the practicality of administering a rescue dose of sugammadex (16 mg/kg) in a simulated CICV scenario.
- To assess the feasibility of creating and utilizing an emergent reversal kit for sugammadex.
- To determine if an emergent reversal kit improves the speed of sugammadex administration.
Main Methods
- A simulation-based quality improvement project involving anesthesia trainees.
- Participants completed CICV scenarios under two conditions: current sugammadex retrieval and use of an emergent reversal kit.
- Time from sugammadex request to administration was recorded and analyzed using a paired t-test (p < 0.001).
Main Results
- The mean time to administer sugammadex decreased from 7.7 minutes without the kit to 2.1 minutes with the kit on the first attempt.
- With practice, time decreased to 2.9 minutes without the kit, and further to 1.4 minutes with the kit on the second attempt.
- A statistically significant reduction in time to reversal was observed with the emergent reversal kit.
Conclusions
- An emergent reversal kit significantly decreases the time required to administer sugammadex in CICV scenarios.
- Improved medication accessibility is crucial for high-stakes emergency situations.
- This novel approach enhances emergency preparedness in anesthesia practice.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...